Could a diabetes drug boost immunotherapy in advanced melanoma?
Disease control
Ongoing
This trial investigates whether adding metformin, a common diabetes drug, to the immunotherapy pembrolizumab (Keytruda) can improve treatment for people with advanced melanoma. The study focuses on reversing metabolic problems inside tumors that may weaken immune cells. Participa…
Phase: PHASE1 • Sponsor: Yana Najjar • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC